Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan · Delayed Price · Currency is TWD 183.50
+3.50 (1.94%)
Aug 12, 2025, 1:30 PM CST
Model N Revenue
Alar Pharmaceuticals had revenue of 1.25M TWD in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 7.07M, down -98.49% year-over-year. In the year 2024, Alar Pharmaceuticals had annual revenue of 5.82M, down -98.76%.
Revenue (ttm)
7.07M
Revenue Growth
-98.49%
P/S Ratio
1,733.78
Revenue / Employee
261.85K
Employees
27
Market Cap
12.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.82M | -463.46M | -98.76% |
| Dec 31, 2023 | 469.27M | 468.47M | 58,559.00% |
| Dec 31, 2022 | 800.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 600.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 40.47M |
| PharmaEssentia | 11.34B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 112.57M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |
| Pegavision | 6.67B |